Innovate Conferences

Innovate Conferences Pharma

Innovate Conferences Pharma

Innovate Pharma 2017
Innovate Home

Welcome Note

We consider it a privilege and a matter of great pride to host theInternational Summit on Pharma & Clinical Trials on June 12-13, 2017. The conference will provide a forum for interaction among attendees on Drugs and Developments in Pharma & Manufacturing, Different Phases of Clinical Trials and New Drug Regulatory Approvals. It will create an interface among professionals, academicians and experts in the fields of Pharma education and research and drug development.

The present efforts to hold the 2017 Innovate Pharma Conference in Sydney, Australia is based on our decision to involve more Australian Global academic faculty members, biopharma representatives and students in this mega event. The Sydney representatives in both industry and academia work with us to create a more interactive association in the fields of Pharma and new drug innovations, not only to promote better job opportunities in the field of Pharmacy and Drug research but also to make the biopharma industry stronger and financially secure.

The 2017 Innovate Pharma Conferences are a hub that covers the core aspects of pharmaceutical sciences including Pharmacology, Analytical and Bioanalytical Technology, Biosimilars, BABE Studies, Toxicology, Clinical Research, Clinical Pharmacology, Antibiotics, Forensic Research, Medicinal Chemistry & CADD, Pharmacognosy, Phytochemistry & Natural Products, Pharmaceutical Regulatory Affairs, Novel Drug Delivery Systems, GMP, GCP & QC’

We cordially invite you to participate in the conference by presenting your work as either talks or posters based on the themes identified above. We hope that you will take advantage of this unique opportunity to interact with eminent scholars, researchers, practitioners and industry representatives from throughout the world whose focus is to develop new and effective drugs to improve world health.

Innovate Pharma 2017
Operating Committee
Innovate Conferences

About Innovate Pharma 2017

The Innovate Pharma 2017 team is the premier pharmaceutical conference event producer. At these pharma conference events, industry professionals are able to discuss the latest industry insights, explore new challenges in drug discovery, development and formulation and well as review case studies in order to understand how best to deal with specific situations. Additionally, Pharma2017 allows stakeholders to build their networks with other industry and academic professionals. The pharmaceutical sciences combine a broad range of scientific disciplines including Clinical Research, Pharmacovigilance, Drug Discovery, Drug Design, Drug Delivery, Drug Action, Drug Analysis, Pharmacoeconomics, and Regulatory Affairs. Pharmaceutical sciences are further subdivided into several specialties: Pharmacology, Pharmacodynamics, Pharmacokinetics, Pharmaceutical Toxicology, Pharmacogenomics, Pharmaceutical chemistry, Pharmaceutics, and Pharmacognosy. The presentations at this conference are international in scope and include the latest in incident response and prevention, vulnerability analysis, and related aspects of Pharmaceutical science. Additionally, these events serve as the foundation for the improvement of worldwide collaborations and interactions via the sharing of viewpoints, ideas, and information on Pharmaceutical science.

Who Should Attend?

You do not need to be a member of Innovate Pharma 2017 to attend the conference. Individuals with responsibility for coordinating a wide range of disciplines in the field of Drug research, development and manufacturing should attend. Attendees will include:

  • Academicians, scientists, clinicians, researchers, surgeons.
  • Health practitioners, Pharmaceutical organizations, Clinical Research organizations
  • Associations and Societies sponsoring the meeting and looking for collaborative partners.
  • Manufacturing Medical Devices Companies (exhibiting).
  • Policy and decision makers with disciplines in the field of Pharmacy.
  • Pharma stakeholders including academic researchers and entrepreneurs , public health clinicians, industry policy makers, veterinarians.

Innovate conferences attract participants representing more than 53 countries around the world.


Innovate Executive Program:

If you are a young scientist who is interested in new drug development and wishes to exchange ideas with industry experts, the INNOVATE EXECUTIVE PROGRAM may well be the event for you. It is a 2 day event held in parallel to the conference, tailored around Pharma Drug Manufacturing and its advances. This program provides a unique opportunity to meet like-minded individuals and share the insights of the world's foremost specialists in Drug development and Clinical applications.

Conference Benefits:

The Innovate Pharma 2017 conference is comprised of scientific sessions, keynote forums, Exhibitions, workshops, symposia and poster presentations where the most recent developments in pharma will be discussed.

Conference Highlights

Global Market Analysis

Overview:

The United States pharmaceutical market together with Canada & Mexico is the world’s important national market and largest continental pharmaceutical market worldwide which holds over 40 percent of the global pharmaceutical market.

The Stastical Results Shows the rapid growth of Pharma Market as follows

  • Over View of the Pharmaceutical Market Till 2015
  • Total nominal spending on medicines in the U.S. - $425bn
  • Pharmacy and drug store sales in the U.S. - $251.73bn
  • U.S. pharmaceutical preparation manufacturing gross output - $207,209m
  • U.S. biopharmaceutical goods export volume - $47bn
  • Revenue of the Pharmaceutical Companies till 2015
  • Pfizer's total revenue - $48,851m
  • Johnson & Johnson's total revenue - $70.1bn
  • Total revenue of Merck & Co.- $39,498m
  • Miscellaneous Values Till 2015 Statistic as Follows
  • Spending of the U.S. pharmaceutical industry for research and development as a percentage of total revenues - 19.8%
  • Number of orphan drug approvals in the U.S.- 24
  • Healthcare and pharmaceutical industry digital advertising spending in the U.S. - $1.93bn

Key Asset of the Pharmaceutical Industry to European Economy till 2015 in Euros

Production 225,000 in which the Exports 361,500 & Imports 275,000, the overall Trade balance 86,500. R&D expenditure 31,500, Normal Employment in units 725,000 and R&D employment units 118,000

Total pharmaceutical market value at ex–factory prices 192,000

pharmaceuticals Payments by statutory health insurance systems in ambulatory care 126,000

Pharmaceutical Market in Asia Pacific

Asia-Pacific region is rapid growing pharmaceutical industry in global pharmaceutical arena. In facts, low operating costs and skilled manpower leads to rapid growth of pharmaceutical companies in Asia Pacific, which now becoming powerhouse of pharmaceutical Research & Development (R&D).

The future of the pharmaceutical industry in the asia pacific region will remains bright & grow around 10% during 2012-2015

Facts of pharmaceutical industry worldwide

  • Revenue of the worldwide pharmaceutical market $1072bn
  • Revenue share of the North American pharmaceutical market 48.7%
  • Pharmaceutical sales in oncologics $78.9bn
  • Statistic of the Companies and Products
  • Sales of Pfizer - $47.4bn
  • Net income of Johnson & Johnson - $15.94bn
  • Sales of Humira - $14.95bn
  • Novartis AG total revenue - $48.5bn
  • Over all outcome Values
  • Contribution to pharmaceutical market growth by Asia/Australia - 36%
  • North American projected global pharmaceutical revenue in 2016 - $574bn
  • Projected global spending on medicines by 2020 - $1,470bn

Global Clinical Trials Market

the USA Clinical Trials total number of studies carried out on 467 drug till 2013 & rapid increase during 2017, most of the trials carried out on Infectious, Genetic Cardiovascular Diseases, cancer, neurological, respiratory disorders, diabetes, Arthritis, & skin disorders and till 2012 children’s participated as subjects are 316. As for funding NIH gave 36.1% for all minorities and 63.9% for white, & in the ratio of 63.1% and 36.9% in male and female. Industry Funded Clinical Trials 16.7% for all minorities and 83.3% for white in the ratio of 47.6% and 52.4% in male and female till 2015

The EU Clinical Trials Register currently displays 29744 clinical trials with a EudraCT protocol, of which 4548 are clinical trials conducted with subjects less than 18 years old.

Asia Pacific is the Key factor for clinical trials in terms of cost, subject availability as well as laws will favor to perform the studies, compare to Europe and America there is a rapid growth in clinical studies as per analysis there is 28% carried out in 2009 – expected to raise to 66% share, Spending includes 23% - in 2009 – 59% till 2030, Clinical Research Organization Approvals raises to 38% as of 2017

Below are the statics given for Industrial funds in asia pacific to Europe (UK) & USA from 2011-2005

Australia 301 – 321 China 217 – 85 Hong Kong 56 – 79 India 154 – 97 Japan 369 – 132 Korea 375 – 113 Malaysia 40 – 51 Philippines 54 – 60 Singapore 76 – 84 Taiwan 141 – 131 Thailand 60 – 73 UK 632 – 502 USA 3,279 - 2,730

Global Pharmaceutical Associations:

    International Associations
  • FIP - International Pharmaceutical Federation
  • IPSF - International Pharmaceutical Students' Federation
    United States
  • AACP - American Association of Colleges of Pharmacy
  • APhA - American Pharmacists Association
  • American Society for Pharmacy Law
  • ASCP - American Society of Consultant Pharmacists
  • American Society of Consultant Pharmacists Foundation
  • ASHP - American Society of Health-System Pharmacists
  • Professional Compounding Centers of America
  • ACCP - American College of Clinical Pharmacy
    Canada
  • Canadian Pharmacists Association
  • Canadian Society of Hospital Pharmacists
    Australia
  • Australian College of Pharmacy
  • Pharmaceutical Society of Australia
  • The Pharmacy Guild of Australia
  • The Society of Hospital Pharmacists of Australia
    European
  • EPhEU - European Association of Employed Community Pharmacists in Europe
  • EPU - European Pharmaceutical Union
  • PGEU - Pharmaceutical Group of the European Union
    New Zealand
  • Pharmaceutical Society of New Zealand
    United Kingdom
  • National Pharmacy Association
  • Pharmaceutical Society of Northern Ireland
  • RPD - Royal Pharmaceutical Society
    India
  • Indian Pharmacist Association
    Ireland
  • Pharmaceutical Society of Ireland


Please Select Valid Input
Please Enter Valid Input
Please Enter Valid Country Name
Please Enter Valid Email
Please Enter Valid Phone Number
Please Select Valid Input
Please select valid file with extesion .doc or .docx
Personal Information
Invalid Selection
Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Selection
Billing Information (Optional)
Registration On/Before April 27th 2017 - Academia On/Before April 27th 2017 - Business On/Before May 31th 2017 - Academia On/Before May 31th 2017 - Business On/Before June 11th 2017 - Academia On/Before June 11th 2017 - Business
Speaker Registration
Package A (Registration + 2 Nights)
Package B (Registration + 3 Nights)
Exhibitor
Poster Presentation
Delegate
Video Presentation
Accompanying Person(s)
Additional Accommodation For Night(s)
Group Participation Academia Business Academia Business Academia Business
5 Participants
10 Participants
15 Participants
Registration On/Before April 27th 2017 On/Before May 31th 2017 On/Before June 11th 2017
Product Category Business Business Business
Royal Package
Others (USD)


Summary

Category Price
TOTAL
**Taxes Applicable**



Heidari
Dr. Alireza Heidari, Ph.D., D.Sc.
Faculty of Chemistry
California South University (CSU)
Irvine, California, USA
Joe Zhou
Dr. Joe X Zhou,
CEO of Genor BioPharma Co. Ltd.,
Walvax Group. China


Esmaiel_Jabbari
Prof. Esmaiel Jabbari,
Professor of Chemical and Biomedical Engineering,
Academic Editor: PLOS ONE,
University of South Carolina.

Pascal
Dr. Pascal Breton, Ph.D,
Président of VitamFero SAS,
University of Orléans (France).

Namrita Lall
Prof Namrita Lall
NRF/DST Chair: Plant health Products from IKS
University of Pretoria
South Africa
Kamali
Kamali Chance,
MPH, Ph.D., RAC,
Vice President, Head, Global Biosimilars Regulatory Strategy,
Biosimilars Center of Excellence, QuintilesIMS, Inc, RTP, North Carolina.
Serge Calet
Serge Calet,
CEO & Founder at IMD-Pharma,
IMD-Pharma, SC2S, Holochem,
France.
Chien-Chin Wu
Dr. Chien-Chin Wu,
CEO - LB Bionano, LLC in USA and LG Bionano (Xiamen) Company LTD,
China.

Mohammed Hmamouchi
Dr. Mohammed Hmamouchi,
Arab Federation of Aromatic and Medicinal Plants,


 Ian MArtins
Ian Martins (PhD),
Centre of Excellence for Alzheimer's Disease Research and Care,
School of Medical Sciences,
Edith Cowan University.
Joondalup.
JInguo James
Dr. James (Jianguo) Yang,
Vice President of Abpro,
CEO of Abpro, China.
Pierre Lutgen
Dr. Pierre Lutgen,
IFBV-BELHERB,
Luxembourg,
Europe.
Stefania Migliuolo
Stefania Migliuolo,
HBA Europe chapter- Marketing & PR Director,
Milan Area, Italy.
David Vincent
David (W) Vincent,
Validation Technologies, Inc. CEO,
VTI Pharmaceutical Technology (Shenzhen) Co. Ltd,
California Coast University,
California.
Joe Martinez
Joe Martinez,
Chief Executive Officer at Center Point Clinical Services LLC,
Valeritas,
Greater New York City Area.
Pierre A. MORGON
Pierre A. MORGON PharmD LL.M MBA,
CEO MRGN Advisors - NED Theradiag, Eurocine Vaccines - Regional Partner Mérieux Développement – 20'500+ Level 1,
Switzerland.

Ahmed Salah
Ahmed Salah,
Chief Executive Officer,
Royal Pharmaceutical LLC Dubai,
United Arab Emirates.
Howe (Hao) Li
Howe (Hao) Li,
Chief Medical Officer at Hangzhou Tigermed Consulting Co., Ltd,
China.

Jomel Vasquez
Prof. Jomel B. Vasquez,
Professor / Clinical Coordinator,
De La Salle University Health Sciences Institute - College of Medical Laboratory Science,
Philippines.
Zohra Jane Esperal
Zohra Jane Esperal,
Clinical Trial Manager, Epidemiologist & Trainer,
Drive MySearch Inc,
Philippines.
No_Image
Brian Kim,
CEO at Biohaus,
Korea.


Please share us below details to Download or View Brochure.
This Field is Mandatory and does not allow numerics
This Field is Mandatory and Valid Email should be entered


Address:

Mercure Sydney International Airport,

22 Levey Street, 2205 Wolli Creek,

Sydney, Australia.

Hotel Features:

  • Shuttle bus service to Sydney Airport – via the domestic and international terminals
  • Secure parking (maximum cost of $25 per day)
  • 24-hour reception
  • 100% non-smoking accommodation
  • Express checkout
  • Wi-Fi Internet access (free for all Le Club Accor Hotels Loyalty members)
  • Wake-up call service
  • Mercure Pillow Menu
  • Dry cleaning and same day laundry service
  • Safety deposit boxes
  • 24-hour in-room dining
  • Go-Get Car share with two vehicles onsite
  • Seasons Restaurant & Bar





ABOUT SYDNEY
Sydney, capital of New South Wales and one of Australia's largest cities, is best known for its harbourfront Sydney Opera House, with a distinctive sail-like design. Massive Darling Harbour and the smaller Circular Quay port are hubs of waterside life, with the arched Harbour Bridge and esteemed Royal Botanic Garden nearby. Sydney Tower’s outdoor platform, the Skywalk, offers 360-degree views of the city and suburbs.

Terms & Conditions

Requesting an Invitation Letter:

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact discover@innovateconferences.com to request a personalized letter of invitation.

All cancellations or modifications of registration must be made in writing to discover@innovateconferences.com

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Innovate Conferences will not directly contact embassies and consulates on behalf of visa applicants. All Attendees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Innovate Conferences, including the inability to obtain a visa.

Privacy Policy

Innovate Conferences are committed to safeguarding the privacy of the users of the Innovate Conferences website, while providing an accommodation which is tailored to suit their desiderata. Please take a moment to read our Privacy Policy as it describes what transpires to the personal information which you supply to Innovate Conferences. Innovate Conferences reserves the right to transmute the terms of this Privacy Policy from time to time

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

Refunds will be issued as follows - only 70% of the refund will be given after regisration & it is not applicable if conference is with in 90 Days. Eligible for 50% refund before 3 months & No refunds will be issued before 1 month of the conference

Abstract Submission

Attendees who are submitted abstracts in our website or by email, are accepting our privacy policy & Innovate Conferences will holds full rights to publish advertise in our websites as well as in our social pages and channels, and also we can publish the abstracts in the form of Electronic & Documents

Registration Prices:

Registration Prices will be subjected to change as per dates and Innovate Conferences will hold full rights in changing the registration prices

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation.

Cancellation Policy:

If Innovate Conferences cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Innovate Conferences which must occur within one year from the date of cancellation.

Postponement

If Innovate Conferences postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Innovate Conferences event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to discover@innovateconferences.com Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Innovate Conferences if the person is unable to attend one of conferences.

Important Note

Registration prices will be vary based on early bird dates and Innovate Conferences has the whole rights to cancel the registration at any time & no one is subjected to take/record the photographs & videos of events. Participants do not have any rights to disturb the events by miscommunication, by objecting, in any other ways, in such cases the respected person/s will not be permitted / allowed to access the event even though if he/she registered, Innovate Conferences holds the whole rights in this

What information does Innovate Conferences hold about you and how is it amassed?

If you register on the Innovate Conferences Sites, your personal information (including your designation, job designation, company's denomination, telephone, fax and mobile numbers, postal and electronic mail address) is amassed by Innovate Conferences. We withal accumulate personal information from you when you contact us by email or otherwise.

In prevalence with many other websites and online accommodations, we may use "cookies" to store and sometimes track information about you, such as your Internet Protocol (IP) address, but only on an incognito substructure. None of the information we store via cookies is linked to personally identifiable information (PPI). A cookie is a scintilla of data sent from the server which is stored on your PC's hard drive. You can set your browser to reluctant cookies or ask your browser to show you where cookies have been set up. Certain accommodations are only activated by the presence of a cookie and, if you opt to abnegate the cookie, a particular on-line feature may not be available to you

What does Innovate Conferences do with your personal information?

All of the personal information described above will be stored on Innovate Conferences utilizer database (unless you notify us that you no longer wish us to retain such information, in which case it will be effaced). Innovate Conferences will only utilize your personal information in order to contact you (for example by email, mail or telephone) for those purposes to which you have previously consented on the site. For example, if you register on the site, if you submit abstract on the site, Innovate Conferences will email to you Innovate Conferences newsletter and, if you wish, contact you about relevant products and services offered by Innovate Conferences or by reputable third parties. If you do not wish to receive information about Innovate Conferences and/or third parties' products and services, you may send an email to support@innovateconferences.com with the subject line unsubscribe and do share the reason.

Innovate Conferences may use Google Analytics for the following purposes:

  • Remarketing (serving ads on 3rd party websites). Innovate Conferences and 3rd-party vendors, including Google, use cookies to serve and target ads based on past visits and interactions with our website.
  • Google Display Network Impression Reporting. Innovate Conferences and 3rd-party vendors use cookies to understand and report on how ad impressions, interactions with ads and other ad services are related to visits to our website.
  • Google Analytics Demographics and Interest Reporting. Innovate Conferences use information from Google's Interest-based advertising or 3rd-party audience data (such as gender, age and interests) with Google Analytics to influence our marketing strategy. Personal information is not captured unless expressly provided by the user. You may opt out of the Google Analytics Display by sending an email to support@innovateconferences.com

To whom is your personal information disclosed?

Innovate Conferences will apportion your personal information with the other members of its group (until if you unsubscribe) will make your denomination and postal address available to reputable third parties so that they can send you details of their products and accommodations. In supplying Innovate Conferences with your personal information, you accede that Innovate Conferences may transfer that information (to the extent that it is still held on our database at the pertinent time) to a third party who acquires all or substantially all or Innovate Conferences assets or stock or our website accommodations whether by merger, acquisition, re-organization or otherwise. Innovate Conferences will not otherwise disclose your personal information to any third parties.

Transfers of personal information overseas

As the cyber world is an ecumenical environment, utilizing the cyber world to amass and process personal information indispensably involves the transmission of that information ecumenical. Innovate Conferences will additionally share your personal information with members of its group which are located overseas. By registering on the Innovate Conferences site and communicating with us, you acknowledge and accede to our processing of your personal information in this way.

When does this Privacy Policy not apply?

This Privacy Policy only applies to the amassment and utilization of data by Innovate Conferences. It does not cover third party sites to which we provide links. Those sites may have their own privacy policies. If you send to us contributions containing personal information to be posted on the Innovate Conferences sites, this information will be publicly accessible and is not covered by this Privacy policy.

How do we forfend your information?

Innovate Conferences is committed to data security. If you subscribe to access our premium content (and, accordingly, enter payment details), Innovate Conferences offers the utilization of a secure server. The secure server software encrypts all information which you input afore it is sent to Innovate Conferences. Innovate Conferences takes steps to sentinel against unauthorized access to the personal information of the users of its site. Albeit it makes every effort to engender a secure environment for your personal information, Innovate Conferences cannot guarantee the safety of any personal information which is transmitted to us online.

Contact us

If you have any questions or concerns about Innovate Conferences use of your personal information, please email at support@innovateconferences.com we will assist you within 10 working days

Scroll To Top